Literature DB >> 24528127

Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia.

Charlene M McShane1, Liam J Murray, Eric A Engels, Lesley A Anderson.   

Abstract

Emerging evidence supports the role of immune stimulation in the development of lymphoplasmacytic lymphoma/Waldenström Macroglobulinaemia (LPL/WM). Using the population-based Surveillance, Epidemiology End Results-Medicare database we investigated the exposure to 14 common community-acquired infections and subsequent risk of LPL/WM in 693 LPL/WM cases and 200 000 controls. Respiratory tract infections, bronchitis [odds ratio (OR) 1·56], pharyngitis (OR 1·43), pneumonia (OR 1·42) and sinusitis (OR 1·33) and skin infection, herpes zoster (OR 1·51) were all significantly associated with subsequent increased risk of LPL/WM. For each of these infections, the findings remained significantly elevated following the exclusion of more than 6 years of Medicare claims data prior to LPL/WM diagnosis. Our findings may support a role for infections in the development of LPL/WM or could reflect an underlying immune disturbance that is present several years prior to diagnosis and thereby part of the natural history of disease progression. Published 2013. This article is a U.S. Government work and is in the public domain in the USA.

Entities:  

Keywords:  community-acquired infection; herpes zoster; infection; lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia; respiratory tract infection

Mesh:

Year:  2013        PMID: 24528127      PMCID: PMC3935765          DOI: 10.1111/bjh.12671

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  23 in total

Review 1.  Clinicopathological definition of Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia.

Authors:  Roger G Owen; Steven P Treon; Ayad Al-Katib; Rafael Fonseca; Philip R Greipp; Mary L McMaster; Enrica Morra; Gerassimos A Pangalis; Jesus F San Miguel; Andrew R Branagan; Meletios A Dimopoulos
Journal:  Semin Oncol       Date:  2003-04       Impact factor: 4.929

2.  Chronic immune stimulation and subsequent Waldenström macroglobulinemia.

Authors:  Jill Koshiol; Gloria Gridley; Eric A Engels; Mary L McMaster; Ola Landgren
Journal:  Arch Intern Med       Date:  2008-09-22

3.  Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.

Authors:  Sigurdur Y Kristinsson; Min Tang; Ruth M Pfeiffer; Magnus Björkholm; Lynn R Goldin; Cecilie Blimark; Ulf-Henrik Mellqvist; Anders Wahlin; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

4.  Use of surveillance, epidemiology, and end results-medicare data to conduct case-control studies of cancer among the US elderly.

Authors:  Eric A Engels; Ruth M Pfeiffer; Winnie Ricker; William Wheeler; Ruth Parsons; Joan L Warren
Journal:  Am J Epidemiol       Date:  2011-08-04       Impact factor: 4.897

5.  Hepatitis C viral infection is not associated with Waldenström's macroglobulinemia.

Authors:  Xavier Leleu; Kelly O'Connor; Allen W Ho; Daniel D Santos; Robert Manning; Lian Xu; Evdoxia Hatjiharissi; Anne-Sophie Moreau; Andrew R Branagan; Zachary R Hunter; Elizabeth A Dimmock; Jacob Soumerai; Christopher Patterson; Irene Ghobrial; Steven P Treon
Journal:  Am J Hematol       Date:  2007-01       Impact factor: 10.047

6.  A long-term study of prognosis in monoclonal gammopathy of undetermined significance.

Authors:  Robert A Kyle; Terry M Therneau; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew F Plevak; L Joseph Melton
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

7.  IgA and IgG hypogammaglobulinemia in Waldenström's macroglobulinemia.

Authors:  Zachary R Hunter; Robert J Manning; Christine Hanzis; Bryan T Ciccarelli; Leukothea Ioakimidis; Christopher J Patterson; Megan C Lewicki; Hsuiyi Tseng; Ping Gong; Xia Liu; Yangsheng Zhou; Guang Yang; Jenny Sun; Lian Xu; Patricia Sheehy; Massimo Morra; Steven P Treon
Journal:  Haematologica       Date:  2009-11-10       Impact factor: 9.941

8.  Potential for cancer related health services research using a linked Medicare-tumor registry database.

Authors:  A L Potosky; G F Riley; J D Lubitz; R M Mentnech; L G Kessler
Journal:  Med Care       Date:  1993-08       Impact factor: 2.983

9.  Monoclonal gammopathy: natural history studied with a retrospective approach.

Authors:  Hlif Steingrimsdottir; Vilhelmìna Haraldsdottir; Isleifur Olafsson; Vilmundur Gudnason; Helga M Ogmundsdottir
Journal:  Haematologica       Date:  2007-08       Impact factor: 9.941

Review 10.  Cancer-related inflammation.

Authors:  Alberto Mantovani; Paola Allavena; Antonio Sica; Frances Balkwill
Journal:  Nature       Date:  2008-07-24       Impact factor: 49.962

View more
  3 in total

1.  Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.

Authors:  Parag Mahale; Elizabeth L Yanik; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

Review 2.  'Trained immunity': consequences for lymphoid malignancies.

Authors:  Wendy B C Stevens; Mihai G Netea; Arnon P Kater; Walter J F M van der Velden
Journal:  Haematologica       Date:  2016-11-10       Impact factor: 9.941

3.  Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.

Authors:  Nicole H Dalal; Graça M Dores; Rochelle E Curtis; Martha S Linet; Lindsay M Morton
Journal:  Br J Haematol       Date:  2020-02-23       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.